次大面积肺栓塞的治疗  

Treatment of submassive pulmonary embolism

作　　者：段宇辰 富路[1] DUAN Yu-chen;FU Lu(Department of Cardiology,First Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang,150001,China)

机构地区：[1]哈尔滨医科大学附属第一医院心内科三病房,黑龙江哈尔滨150001

出　　处：《心血管康复医学杂志》2018年第2期221-224,共4页Chinese Journal of Cardiovascular Rehabilitation Medicine

摘　　要：肺栓塞(PE)已经成为公共健康的重大威胁,根据严重程度它分为高危(大面积)、中危(次大面积)和低危(非大面积)。高危和低危PE的治疗已得到共识,但中危PE的最佳治疗尚不明确。本文对次大面积PE围治疗期的最佳方案的研究进展作一综述。Pulmonary embolism(PE)has become a major threat to public health.According to its severity,it can be divided into high risk PE(massive),intermediate risk PE(submassive)and low risk PE(non-massive).Treatment of high risk and low risk PE has reached a consensus,however,optimal therapy of intermediate risk PE is still not clear.The present article made a review on research progress of optimal treatment for submassive PE.

关 键 词：肺栓塞 血栓溶解疗法 抗凝药 

分 类 号：R563.5[医药卫生—呼吸系统]